Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions

specific

A group of renal cell carcinomas characterized by the presence of different translocations involving the chromosome Xp11.2. These translocations result in the creation of gene fusions involving the TFE3 gene. Patients are usually children and young adults. Morphologically, the malignant epithelial cells form papillary patterns.

57

Centers

57

Active Trials

Cancer Funding

Top Centers for Renal Cell Carcinoma Associated With Xp11.2 Translocations/TFE3 Gene Fusions(57)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
50.9
2
NCI Comprehensive
Active Research Program
50.9
3
NCI Comprehensive
Active Research Program
50.9
4
NCI Comprehensive
Active Research Program
50.9
5
NCI Comprehensive
Active Research Program
50.9
6
NCI Comprehensive
Active Research Program
50.9
7
NCI Comprehensive
Active Research Program
50.9
8
NCI Comprehensive
Active Research Program
50.9
9
NCI Comprehensive
Active Research Program
50.9
10
NCI Comprehensive
Active Research Program
50.9
11
NCI Comprehensive
Active Research Program
50.9
12
NCI Comprehensive
Active Research Program
50.9
13
NCI Comprehensive
Active Research Program
50.9
14
NCI Comprehensive
Active Research Program
50.9
15
NCI Comprehensive
Active Research Program
50.9
1650.9
17
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
50.9
18
NCI Comprehensive
Active Research Program
50.9
19
NCI Comprehensive
Active Research Program
50.9
20
NCI Clinical
Active Research Program
50.9
21
NCI Comprehensive
Active Research Program
50.9
22
NCI Comprehensive
Active Research Program
50.9
23
NCI Clinical
Active Research Program
50.9
24
NCI Comprehensive
Active Research Program
50.9
25
Active Research Program
50.9
26
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
50.9
27
Active Research Program
50.9
28
Active Research Program
50.9
29
NCI Comprehensive
Active Research Program
50.9
30
NCI Clinical
Active Research Program
50.9
31
NCI Comprehensive
Active Research Program
50.9
32
NCI Comprehensive
Active Research Program
50.9
33
NCI Comprehensive
Active Research Program
50.9
34
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
50.9
35
Active Research Program
50.9
36
NCI Clinical
Active Research Program
50.9
37
NCI Comprehensive
Active Research Program
50.9
38
Active Research Program
50.9
39
Active Research Program
50.9
40
NCI Comprehensive
Active Research Program
50.9
4150.9
42
Active Research Program
50.9
43
Active Research Program
50.9
44
Active Research Program
50.9
45
Active Research Program
50.9
46
Active Research Program
50.9
47
Active Research Program
50.9
48
Active Research Program
50.9
49
Active Research Program
50.9
50
Active Research Program
50.9
5150.9
52
Active Research Program
50.9
53
Active Research Program
50.9
54
BC CancerVancouver, BC
Active Research Program
50.9
55
Active Research Program
50.9
56
Active Research Program
50.9
57
Active Research Program
50.9

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →